"combination treatment" trang 4 - tải miễn phí từ tailieunhanh
Using Power Management™

Using Power Management™
60    55    1
ECMWF Newsletter No. 128 – Summer 2011

ECMWF Newsletter No. 128 – Summer 2011
31    45    1
MEDIA TRAINING GUIDELINES CALL FOR PROPOSALS EACEA 2012

MEDIA TRAINING GUIDELINES CALL FOR PROPOSALS EACEA 2012
31    77    1
Sheep: Sustainable and Organic Production

Sheep: Sustainable and Organic Production
24    60    0
A Comparative Analysis of Carbon Dioxide Emissions in Coated Paper Production Key Differences between China and the U.S.

A Comparative Analysis of Carbon Dioxide Emissions in Coated Paper Production Key Differences between China and the U.S.

53    78    0
THE DREAMING CITY GLASGOW 2020 AND THE POWER OF MASS IMAGINATION

THE DREAMING CITY GLASGOW 2020 AND THE POWER OF MASS IMAGINATION
122    48    0
Anti tumor effects of combination measles vaccine virus and nimotuzumab treatment on nude mice bearing human larynx cancer

Anti tumor effects of combination measles vaccine virus and nimotuzumab treatment on nude mice bearing human larynx cancer
8    92    0
Vinorelbine as second-line treatment of NSCLC after the failure of platinum-taxane combination at the Hue University hospital

Vinorelbine as second-line treatment of NSCLC after the failure of platinum-taxane combination at the Hue University hospital
5    87    1
PRISM protocol: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in firstline treatment of patients with advanced or metastatic renal cell carcinoma

PRISM protocol: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in firstline treatment of patients with advanced or metastatic renal cell carcinoma
9    85    0
Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma

Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma
10    68    0
Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment

Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment
15    79    1
A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)

A randomized phase II study of paclitaxel alone versus paclitaxel plus sorafenib in second- and third-line treatment of patients with HER2-negative metastatic breast cancer (PASO)
9    72    1
Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: A randomized controlled trial

Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: A randomized controlled trial
9    47    1
The regulation of combined treatmentinduced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells

The regulation of combined treatmentinduced cell death with recombinant TRAIL and bortezomib through TRAIL signaling in TRAIL-resistant cells
12    66    1
INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: The combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies

INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: The combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies
11    58    1
Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin

Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin
10    28    1
Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma

Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma
15    77    1
Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: A single center experience

Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: A single center experience
8    30    1
Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms

Molecular targeted photoimmunotherapy for HER2-positive human gastric cancer in combination with chemotherapy results in improved treatment outcomes through different cytotoxic mechanisms
10    51    1
Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): A multicenter, phase II trial

Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): A multicenter, phase II trial
9    59    1